EMA — authorised 26 September 2017
- Marketing authorisation holder: Advanced Accelerator Applications
- Status: approved
🇪🇺 Lutathera in European Union
EMA authorised Lutathera on 26 September 2017
Marketing authorisation
Lutathera in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Lutathera approved in European Union?
Yes. EMA authorised it on 26 September 2017.
Who is the marketing authorisation holder for Lutathera in European Union?
Advanced Accelerator Applications holds the EU marketing authorisation.